{
    "code": 0,
    "data": [
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Written Transcript of Earnings Conference Call held on November 17 2025 at 04:30 p.m. is attached herewith.",
            "news_id": "10c7ec5c-e15d-4819-87f0-56db752bd5db",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6af98254-696a-4db7-ab64-c79d4d040ee4.pdf",
            "news_date": "2025-11-21 18:40:28",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Audio Recording of the Earnings Conference Call held on November 17 2025 at 04:30 p.m. has been uploaded on the Companys website and can be accessed through the link: http://gufic.com/Notice/AudioRecording_141125.mp3 \r\n\r\nWritten transcript of the same will be submitted in due course.",
            "news_id": "73cde1cd-4128-4914-a7c9-ac8feb30e01c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9e0f0dd-88cf-4d55-a6cf-a778cb298c53.pdf",
            "news_date": "2025-11-17 19:21:46",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025 is attached herewith",
            "news_id": "1105d410-0ff0-412c-8105-1c479bfedea3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2029e06-73d2-4994-b812-c2bea38f695b.pdf",
            "news_date": "2025-11-14 19:53:05",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended September 30 2025 is attached herewith.",
            "news_id": "ba8d352e-6715-44df-99f3-d4f22fb590ac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a62f955-5bbc-454d-82e1-7681a565ef80.pdf",
            "news_date": "2025-11-14 19:18:34",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Written Transcript of Earnings Conference Call held on August 14 2025 at 12:00 p.m. is attached herewith.",
            "news_id": "43117433-40ce-4a43-9ae7-aca1d6614e43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1241e9e4-297b-4c90-948a-934d15a991d0.pdf",
            "news_date": "2025-08-20 17:36:36",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference Call held on August 14 2025 at 12:00 p.m. is attached herewith.",
            "news_id": "675a7eae-1b75-486f-b088-18ac09e524c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=768378fb-5c9d-44f0-89c6-bc44ac75284c.pdf",
            "news_date": "2025-08-14 17:27:53",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Unaudited Financial Results of the Company for the quarter ended June 30 2025 is attached herewith",
            "news_id": "82662d25-8b66-48d2-8fc7-5af1148345b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14134779-988a-41c8-89a1-382acc0ee34f.pdf",
            "news_date": "2025-08-13 20:19:37",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025",
            "news_body": "Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2025 is attached herewith\r\n",
            "news_id": "6cb39d82-15b5-47fc-9f8a-baf2877f1a75",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=099e19f6-2deb-476e-b09a-10ab39e005df.pdf",
            "news_date": "2025-08-13 19:01:51",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Written Transcript of Earnings Conference Call held on June 02 2025 at 04:30 p.m. is attached herewith",
            "news_id": "3a149784-ff23-4698-a899-17827b03541c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b673a41-e281-47f3-88d5-996f30146f08.pdf",
            "news_date": "2025-06-06 17:09:15",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference Call is attached herewith.",
            "news_id": "5783723e-2d4f-4f00-a25b-f61349de4628",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91ab26e8-d637-4017-bfa5-bcfe1c8c586b.pdf",
            "news_date": "2025-06-02 19:21:31",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Audited Financial Results of the Company for the quarter and financial year ended March 31 2025 is attached herewith",
            "news_id": "9d0557e5-7211-43d1-afda-fea00a313590",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cf858ae-8ac9-4341-b4ca-602c590b06e0.pdf",
            "news_date": "2025-05-30 21:44:39",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Audited (Standalone And Consolidated) Financial Results For The Quarter And Financial Year Ended March 31 2025",
            "news_body": "Audited (Standalone and Consolidated) Financial Results for the Quarter and Financial Year ended March 31 2025 is attached herewith",
            "news_id": "b2d75494-f88d-40f0-b731-8e5b96129e05",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7431f37-4e29-4dcd-86e8-493a425e205f.pdf",
            "news_date": "2025-05-30 19:37:00",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Written Transcript of Earnings Conference Call is attached herewith.",
            "news_id": "03e99ccb-144d-432c-80bc-ea5187297232",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=973bbadd-6928-4d3c-a134-cf32232ad5aa.pdf",
            "news_date": "2025-02-21 14:32:08",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation is attached herewith.",
            "news_id": "9fd2ae65-4669-4012-be65-a8a833daa666",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75111bd7-47c4-4cac-9815-c9b094c05ef4.pdf",
            "news_date": "2025-02-14 18:30:20",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2024 is attached herewith.",
            "news_id": "3e4c5f74-a820-4d6e-92e9-cc5706a6009f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8061294b-2dde-481a-9c09-be1ed6392ebf.pdf",
            "news_date": "2025-02-14 18:27:11",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Written Transcript of Earnings Conference Call held on November 18, 2024 at 04:00 PM, is attached herewith.",
            "news_id": "1db38dd5-9b54-44f7-9fc5-8f65545dcb81",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=655fc6e6-3697-4592-b1a9-7318497b5c66.pdf",
            "news_date": "2024-11-22 18:50:59",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Recording of the Earnings Conference Call held on November 18, 2024 at 04:00 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AudioRecording_141124.mp3 Written transcript of the same will be submitted in due course.",
            "news_id": "c47880d3-b7f8-4f32-9379-e27590dab0b3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=966835d8-131e-4f41-b3ce-6b68f4db0085.pdf",
            "news_date": "2024-11-18 20:45:05",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation is attached herewith.",
            "news_id": "b045f6ec-ba15-4fd9-83a7-3cd6b0ccdcac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05e0d377-84d4-47ad-a7ef-65aef829c634.pdf",
            "news_date": "2024-11-14 21:16:06",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2024 is attached herewith.",
            "news_id": "efdf0e1e-fad3-4081-a1df-f422c1726f47",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93aaed47-0368-4f53-83b9-368becc1f96d.pdf",
            "news_date": "2024-11-14 19:33:07",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Written Transcript of Earnings Conference Call held on August 14, 2024 at 5:30 p.m. is attached herewith.",
            "news_id": "c84c4930-1af1-4256-aace-b7a8f6955a67",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7d0d9da-6206-47e7-9957-696f94289594.pdf",
            "news_date": "2024-08-20 19:17:03",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Recording of the Earnings Conference Call held on August 14, 2024 at 05:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AudioRecording_140824.mp3.Written transcript of the same will be submitted in due course.",
            "news_id": "a96b3f14-17f8-450c-9755-c159fcc9e008",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c366dc3-b692-4191-b3f3-784d69ffba45.pdf",
            "news_date": "2024-08-14 19:52:06",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Unaudited Financial Results of the Company for the quarter ended June 30, 2024 is attached herewith.",
            "news_id": "17dab8c3-f6c9-47d7-9388-ace6da18f5b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68f52b64-9312-4449-b70a-7c292b48a4da.pdf",
            "news_date": "2024-08-14 15:42:40",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2024",
            "news_body": "Unaudited Financial Results (Standalone and Consolidated) along with Limited Review Report for the quarter ended June 30, 2024 is attached herewith.",
            "news_id": "8ad5b282-bca9-4e74-99d0-121b69894537",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b100bbcd-975e-4e56-a2a3-c98ee75e0562.pdf",
            "news_date": "2024-08-14 15:20:04",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Written Transcript of Earnings Conference Call held on May 30, 2024 at 4:30 p.m. is attached herewith.",
            "news_id": "ab6b0109-84c4-4f2d-b73a-ea2175ef0d81",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a303060c-ece8-411d-b416-540ba783ab64.pdf",
            "news_date": "2024-06-05 19:08:30",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Recording of the Earnings Conference Call held on May 30, 2024 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/GUF0220240530153526.mp3   Written transcript of the same will be submitted in due course.",
            "news_id": "ee362cf1-3e99-4625-970c-4782704f44b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40cde87a-31f3-4c85-8870-5358ebc3b902.pdf",
            "news_date": "2024-05-30 18:46:48",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Audited Financial Results of the Company for the quarter and financial year ended March 31, 2024 is attached herewith.",
            "news_id": "41b9f3aa-abb4-422a-ae8e-3131f4f68df5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ab97641-02da-437c-918b-09fd440e66a6.pdf",
            "news_date": "2024-05-29 21:09:52",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Audited Financial Results For The Quarter And Financial Year Ended March 31, 2024",
            "news_body": "The Outcome of Board Meeting held on 29.05.2024 is attached herewith.",
            "news_id": "a3bf3053-0fb2-4ea9-97a7-f5290f404779",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9050565-36e3-41f0-8df0-4753fa725a9c.pdf",
            "news_date": "2024-05-29 20:54:02",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Written Transcript of Earnings Conference Call held on February 16, 2024 at 4:30 p.m. is attached herewith.",
            "news_id": "b8e14751-bc85-40f4-901c-a50d9146a505",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7032e720-1b4d-4c0c-aea2-e1da3d0edacf.pdf",
            "news_date": "2024-02-21 18:43:01",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Recording of the Earnings Conference Call held on February 16, 2024 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/GUF0220240216151762.mp3Written transcript of the same will be submitted in due course.",
            "news_id": "707d7953-8769-49e1-b8ca-dd536b2ff5bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c70f1047-722d-4b4b-bcd4-0de2485fcfd4.pdf",
            "news_date": "2024-02-16 19:10:44",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2023 is attached herewith.",
            "news_id": "4f1bf8ca-2ad4-47eb-9afd-effca9e174a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52809fe6-5412-439b-8f11-10ad836954da.pdf",
            "news_date": "2024-02-14 20:11:26",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2023 along with Limited Review Report thereon, is enclosed herewith.",
            "news_id": "390a7232-0ae0-44e2-9cdf-c8949db6e870",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a58ef6ac-03ee-489d-9cae-d3538d0ba4ab.pdf",
            "news_date": "2024-02-14 17:57:13",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The written transcript of the Earnings Conference Call held on November 17, 2023 at 04:30 PM has been uploaded on the Company''s website.",
            "news_id": "cb890013-5fa9-457d-9511-488d933428f6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d3af520-0c48-4403-a2fe-8d50d27d79a8.pdf",
            "news_date": "2023-11-23 11:08:32",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Call Recording of the Earnings Conference Call held on November 17, 2023 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AUDIORECORDING_17112023.mp3Written transcript of the same will be submitted in due course.",
            "news_id": "bfe652f7-f0af-4f99-9da4-e7d8e7a8155d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae9c73f5-648f-4316-994b-f92b0a3b168a.pdf",
            "news_date": "2023-11-17 18:54:41",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Investor Presentation on Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023.",
            "news_id": "c6c81758-7773-4ac3-bc62-9013826c1b4b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8411afc-2b84-4f58-836a-6fd78852939b.pdf",
            "news_date": "2023-11-17 14:04:08",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Please find attached herewith Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended September 30, 2023",
            "news_id": "99b0879d-d075-42d2-a919-3d84979e8e1c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab57a8a5-b222-48ba-bfde-1c14d72a4041.pdf",
            "news_date": "2023-11-09 17:57:55",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is in continuation to our communication dated August 14, 2023 on Earnings Conference Call and pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on August 14, 2023 at 4:30 p.m., has been uploaded on the Company''s website which can be accessed through the link: http://gufic.com/Notice/WrittenTranscript_1408223.pdf",
            "news_id": "293b33e1-a7de-4ceb-ac5c-b09ce847698d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=daa06e9c-e567-4a30-be60-50c9855b83c5.pdf",
            "news_date": "2023-08-18 18:21:21",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Call Recording of the Earnings Conference Call held on August 14, 2023 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AUDIORECORDING_14082023.mp3Written transcript of the same will be submitted in due course.",
            "news_id": "6d01a7a5-6286-4b40-b7a0-9d09f3550499",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=419524b6-3641-4b32-b5fe-415a9821f18c.pdf",
            "news_date": "2023-08-14 19:12:06",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Unaudited Financial Results of the Company for the Quarter ended June 30, 2023.",
            "news_id": "2858a655-e0a5-4cd4-ad52-4ed938896937",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91c40893-f489-4610-afa8-2ac7939d9d02.pdf",
            "news_date": "2023-08-11 18:02:42",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "In compliance with Regulation 30 and 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform that the Board of Directors of the Company at its meeting held today i.e., Friday, August 11, 2023 inter alia, considered and approved Unaudited Financial results of the Company for the quarter ended June 30, 2023 along with Limited Review Report issued thereon.<BR>",
            "news_id": "4b990dfb-0026-425e-aace-949642c402ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=199b4d47-44b2-4b26-b702-99b82349df7f.pdf",
            "news_date": "2023-08-11 17:27:12",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is in continuation to our communication dated May 30, 2023 on Earnings Conference Call and pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on May 30, 2023 at 4:30 p.m., has been uploaded on the Company's website which can be accessed through the link: http://gufic.com/Notice/WrittenTranscript_3005223.pdf",
            "news_id": "cdf167b6-3861-4165-a119-dfc8de591192",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ef8e483-10c9-4f3c-b7ea-ddbf96b778c9.pdf",
            "news_date": "2023-06-02 18:23:58",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Call Recording of the Earnings Conference Call held on May 30, 2023 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AUDIORECORDING_30052023.mp3 Written transcript of the same will be submitted in due course.",
            "news_id": "7e7f7dea-7fe8-405e-a966-593c8ac9ede2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd55298e-7078-48df-a1e9-458e2198136b.pdf",
            "news_date": "2023-05-30 19:28:02",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Audited Financial Results of the Company for the quarter and financial year ended March 31, 2023",
            "news_id": "145ac20d-0194-467d-b0e8-8b0683da370a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa9ca8c0-069a-49ae-8032-f787ac518494.pdf",
            "news_date": "2023-05-29 20:30:57",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Meeting Held On Monday, May 29, 2023",
            "news_body": "In compliance with Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform that the Board of Directors of the Company at its Meeting held today i.e. Monday, May 29, 2023, inter alia, considered and approved the following:<BR> <BR> 1. The Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023 along with the Auditors Report. <BR> <BR> 2. Recommended Dividend @ 10% i.e. Re. 0.10 per equity share (Face Value of Re. 1/- each) for the Financial Year ended March 31, 2023, subject to the approval of the Shareholders at the ensuing Annual General Meeting.<BR>",
            "news_id": "6dc7550a-0250-4f45-9372-6b7212c044a7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2587c86f-2759-4f16-b6f2-e47439688956.pdf",
            "news_date": "2023-05-29 19:05:38",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Audited Financial Results For The Quarter And Financial Year Ended March 31, 2023",
            "news_body": "In compliance with the Regulation 30 and 33 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, this is to inform that the Board of Directors of the company at its meeting held today i.e., Monday, May 29, 2023 inter alia considered and approved the Audited Financial Results of the company for the quarter and year ended March 31, 2023 along with the Auditors Report.",
            "news_id": "5a2d00ba-137a-4806-9cbd-4513ba89dd98",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b618cc5-bf59-4b65-a546-c5fa47ecd60c.pdf",
            "news_date": "2023-05-29 18:57:52",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is in continuation to our communication dated February 20, 2023 on Earnings Conference Call and pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on February 20, 2023 at 4:30 p.m., has been uploaded on the Company's website which can be accessed through the link: http://gufic.com/Notice/WrittenTranscript_200223.pdf",
            "news_id": "18eba2c4-3047-4822-939d-6f9b39349cd4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3136ffb1-7019-420a-ba5d-0ae2cad44fbb.pdf",
            "news_date": "2023-02-24 17:55:38",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Call Recording of the Earnings Conference Call held on February 20, 2023 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AUDIORECORDING_20022023.mp3   Written transcript of the same will be submitted in due course.",
            "news_id": "f4732519-9e09-4a20-9ae1-525186977a2f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b53b437d-d6b9-4a1c-8ec0-12a0faf1296a.pdf",
            "news_date": "2023-02-20 19:02:03",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results -Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. Friday, February 10, 2023, inter alia, considered and approved:<BR> <BR> 1. The Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review Report thereon. Copies of the same are enclosed herewith.<BR> <BR> 2. Re-appointment of M/s. Manish Ghia & Associates, Practicing Company Secretaries, Mumbai as the Secretarial Auditor of the Company to conduct Secretarial Audit of the Company for the Financial year 2022 -23 and issue report thereon.<BR> <BR> The meeting of the Board of Directors commenced at 4:30 p.m. and concluded at 6:15 p.m.",
            "news_id": "a67e0427-5404-4684-a050-b11af90d1c0a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39e7d3bd-bc05-472e-ab8a-0d539909632d.pdf",
            "news_date": "2023-02-10 18:33:07",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions of the Company in the prescribed format for the half year ended September 30, 2022.",
            "news_id": "f4651a18-900b-45d5-aad3-f92c9e77e522",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d01c50d1-fd61-411a-b100-10debe802636.pdf",
            "news_date": "2022-11-25 20:03:59",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is in continuation to our communication dated November 14, 2022 on Earnings Conference Call and pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on November 14, 2022 at 4:30 p.m., is enclosed herewith and has also been uploaded on the Company's website which can be accessed through the link: http://gufic.com/Notice/Written%20Transcript%20141122.pdf",
            "news_id": "bda67bc4-ff2f-493a-89b3-6c292648dd3b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9ca9cd1-a332-4845-816d-5dd1641e9363.pdf",
            "news_date": "2022-11-18 19:08:00",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Call Recording of the Earnings Conference Call held on November 14, 2022 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AUDIORECORDING_14112022.mp3  Written transcript of the same will be submitted in due course.",
            "news_id": "62781f27-d132-4104-a197-ba844b7dc727",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adb928f4-a91a-4ae7-8259-d98b05281679.pdf",
            "news_date": "2022-11-14 20:01:02",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Un-Audited Financial Results for the quarter and half year ended September 30, 2022.",
            "news_id": "e9ceb966-b382-4846-9b7b-5c39e2d6c8d1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=728eea21-215e-40e1-8040-b49536c41354.pdf",
            "news_date": "2022-11-11 19:52:25",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. Friday, November 11, 2022, inter alia, considered and approved the Un-Audited Financial Results for the quarter and half year ended September 30, 2022.<BR> <BR> In this regard, we are enclosing herewith the following:<BR> <BR> 1. Un-Audited Financial Results for the Quarter and Half Year ended September 30, 2022 <BR> 2. Limited Review Report received from the Statutory Auditor of the Company on the Un-Audited Financial Results for the Quarter and Half Year ended September 30, 2022. <BR> 3. Investor Presentation on the Financial Results.<BR> <BR> The meeting of the Board of Directors commenced at 3:00 p.m. and concluded at 7:10 p.m.<BR>  <BR>",
            "news_id": "63ff753f-5477-4d40-86e0-d521a6b8c053",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3d9b924-9f92-453b-84ea-45fe09fd8174.pdf",
            "news_date": "2022-11-11 19:30:06",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is in continuation to our communication dated August 12, 2022 on Earning Conference Call and pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on August 12, 2022 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link:http://gufic.com/Notice/Written%20Transcript%20120822.pdf Kindly take the same on record.",
            "news_id": "f1480aea-a1ce-4095-a593-29eace8e3199",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a3f0fba-f01b-459b-8e58-5b10303a3520.pdf",
            "news_date": "2022-08-18 18:54:38",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Financial Results for the quarter ended June 30, 2022.Kindly take the same on record.",
            "news_id": "877b9dd3-bbd6-445f-bf06-e1b78fa2c791",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed420393-0b92-4ee8-9451-aa3c9286e509.pdf",
            "news_date": "2022-08-11 21:23:19",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform that the Board of Directors of the Company at its Meeting held today i.e. Thursday, August 11, 2022, inter alia, considered and approved the Unaudited Financial Results along with the Limited Review Report for the quarter ended June 30, 2022,  which has been duly reviewed and recommended by the Audit Committee.<BR> <BR> In this regard, we are enclosing herewith the following:<BR> 1. Un-Audited Financial Results for the Quarter ended June 30, 2022. <BR> 2. Limited Review Report received from the Statutory Auditor of the Company on the Un-Audited Financial Results for the Quarter ended June 30, 2022. <BR> 3. Investor Presentation on the financial results.<BR> <BR> The meeting of the Board of Directors commenced at 6:00 p.m. and concluded at 9:00 p.m.<BR> <BR> <BR> <BR>",
            "news_id": "7f2303ae-6e7d-489a-89f7-b6ea2040eaf8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd5aa9f6-7beb-40c6-b9fb-ac1c71ca80b3.pdf",
            "news_date": "2022-08-11 21:14:47",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of disclosure pertaining to Related Party Transactions of the Company for the half year ended March 31, 2022.Kindly take the same on record.",
            "news_id": "15c1d61d-4326-4058-940c-e057ddca4618",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8e6e463-7e52-4751-97bb-ae37d17ebbec.pdf",
            "news_date": "2022-06-03 19:47:10",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is in continuation to our communication dated May 23, 2022 on Earning Conference Call and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on May 23, 2022 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/Transcript%20of%20Q4%20Earning%20Call.pdf Kindly take the same on record.",
            "news_id": "8b168ce4-4216-465c-8421-7ce70b265b36",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d40f8daa-b093-4478-beaf-4aff60d00032.pdf",
            "news_date": "2022-05-27 15:21:07",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the Earnings Conference Call held on May 23, 2022 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AUDIORECORDING_23052022.mp3 Written transcript of the same will be submitted in due course.Kindly take the same on record.",
            "news_id": "8f8e4530-7008-4eb6-8e09-e6dda1670b6e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=628a00fd-5813-4561-8ff8-abaa05cdf791.pdf",
            "news_date": "2022-05-23 19:42:04",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Of Directors Meeting Held On Friday, May 20, 2022",
            "news_body": "In compliance with Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform that the Board of Directors of the Company at its Meeting held today i.e. Friday, May 20, 2022, inter alia, considered and approved the following:<BR> 1. The Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2022 along with the Auditors Report.<BR> 2. Recommended Dividend @ 10% i.e. Re. 0.10 per equity share (Face Value of Re. 1/- each) for the Financial Year ended March 31, 2022, subject to the approval of the Shareholders at the ensuing Annual General Meeting.",
            "news_id": "23b55d79-46d7-4fc7-bad6-1803cb6035dd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4d149b4-5acd-4709-8328-1b06851b3a1b.pdf",
            "news_date": "2022-05-20 19:20:36",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Audited Financial Results For The Quarter And Year Ended March 31, 2022",
            "news_body": "In compliance with Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Board of Directors of the Company at its Meeting held today i.e. Friday, May 20, 2022, inter alia, considered and approved the Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2022 along with the Auditors Report. <BR> <BR> We are enclosing herewith copies of: <BR> <BR> i. Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2022<BR> ii. Auditor's Report issued by M/s. Mittal Agarwal & Co., Chartered Accountants (FRN - 131025W), Statutory Auditors of the Company for the Financial Year ended March 31, 2022<BR> iii. Declaration on Auditors Report with unmodified opinion on the Audited Financial Results of the Company for the Financial Year ended March 31, 2022. <BR> iv. Investor Presentation.  <BR> <BR>",
            "news_id": "0a7ecf89-5b3b-4b7d-b7b9-f8ca15865bcb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef5529fc-0c29-4867-b2ed-11d77204bfce.pdf",
            "news_date": "2022-05-20 19:16:20",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is in furtherance to our communication dated February 10, 2022 on Earning Conference Call and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on February 10, 2022 at 4: 30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/Transcript%20of%20Q3%20Earning%20Call.pdfKindly take the same on record.",
            "news_id": "2c1e6efd-ecc8-4ccc-b162-da5b58c791dd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0370c6d4-b7af-4711-a424-5d82becbfd16.pdf",
            "news_date": "2022-02-14 19:26:16",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the Earnings Conference Call held on February 10, 2022 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link:  http://gufic.com/Notice/AUDIORECORDING_10022022.mp3Written transcript of the same will be submitted in due course.Kindly take the same on record.",
            "news_id": "711ebc52-80a4-4e9f-893c-9e0698bebd10",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05af1656-e2d3-43bb-bbac-68518c9b79bd.pdf",
            "news_date": "2022-02-10 21:39:58",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Un-Audited Financial Results For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "Pursuant to the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we would like to inform that the Board of Directors at their meeting held on February 09, 2022 i.e., today, inter alia considered and approved the following matters:<BR> <BR> 1. Un-audited Financial Results of the Company for the quarter and nine months ended December 31, 2021;<BR> In terms of provisions of Regulation 33 of the Listing Regulations, we enclose herewith the following :<BR> i. Un-Audited Standalone Financial Results for the quarter and nine months ended December 31, 2021;<BR> ii. Limited Review Report issued by the Statutory Auditor of the Company on the Un-Audited Financial Results for the quarter and nine months ended December 31, 2021;<BR> iii. Investors' Presentation<BR> <BR> The Board of Directors meeting commenced at 04:00 p.m. and concluded at 7.00 p.m.<BR> <BR> Kindly take the same on your record.<BR>",
            "news_id": "a70739e8-d6b9-4e12-8aa7-b537240c3b03",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5475bb1a-dd84-4471-a3d6-55ca3c9afdd8.pdf",
            "news_date": "2022-02-09 19:04:59",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is in furtherance to our communication dated November 10, 2021 on Earning Conference Call and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on November 10, 2021 at 5:00 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/Transcript%20of%20Q2%20Earning%20Call.pdf<BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "83ddb6c5-2a1c-4130-ab9c-e133364fa2ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d826beb2-da37-4b84-a950-110119c92c1c.pdf",
            "news_date": "2021-11-16 11:08:53",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations 2015, audio call recording of the Earnings Conference Call held on 10th November, 2021 at 5:00 p.m. has been uploaded on the Company's website and can be accessed through the  below link:<BR> http://gufic.com/Notice/AUDIORECORDING_10112021.mp3<BR>  <BR> Written transcript of the same will be submitted in due course.<BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "a4df941d-e674-48b3-b311-b064070520b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=768d31a1-324f-47c0-97e4-d5bb77f8cb7a.pdf",
            "news_date": "2021-11-10 19:26:46",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Regulations'), we wish to inform you that the Board of Directors of the Company at its meeting held on   November 03, 2021 inter alia considered and approved the Un-audited Financial Results of the Company for the Quarter and Half Year ended September 30, 2021. <BR> <BR> In terms of provisions of the said Regulations, we are enclosing herewith a copy of the Un-Audited Financial Results along with Limited Review Report received from the Statutory Auditor of the Company for the Quarter and Half Year ended September 30, 2021.<BR> <BR> The meeting of the Board of Directors commenced on November 03, 2021 at 5:00 p.m. and concluded at 6.20 p.m.<BR> <BR> The Q2 Earning Conference Call of the Company is scheduled to be convened on Wednesday, November 10, 2021 at 5:00 p.m., the details of which shall be intimated shortly.<BR> <BR>",
            "news_id": "730b86e1-859e-4241-a84e-9c2c31f9aacc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfa27c4b-5758-43e1-8934-22d81259c244.pdf",
            "news_date": "2021-11-03 18:28:43",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Further to our communication dated August 13, 2021 on Earning Conference Call and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the said call held on August 12, 2021 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/Written%20Transcript.pdf<BR> <BR> Kindly take the same on record.",
            "news_id": "200db0f3-9372-476e-bbb4-9bb66f4f42df",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e966484b-34c5-439c-9f3f-90e7d2579ecf.pdf",
            "news_date": "2021-08-17 14:02:03",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Conference Call Conducted On August 12, 2021",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations 2015, audio call recording of the earnings call held on 12th August, 2021 at 5:00 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AUDIORECORDING_12082021.mp3<BR> <BR> Written transcript of the same will be submitted in due course.<BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "ef8ab0ea-d281-4d78-9ed9-e00b4a482c1d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b89a77d0-2772-4803-a9db-106815e6b6af.pdf",
            "news_date": "2021-08-13 12:30:53",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors",
            "news_body": "The Board of Directors of the Company at its Meeting held on August 11, 2021, which commenced at 4.00 p.m. and concluded at  7.40  p.m., inter alia considered and approved the following:<BR> 1. The Un-Audited Financial Results for the quarter ended June 30, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> 2. The Board of Directors on the recommendation of the Nomination and Remuneration Committee, subject to the approval of shareholders at the ensuing Annual General Meeting approved re-appointment of Dr. Anu Aurora (DIN: 05120192) as an Independent Director of the Company, whose current term will expire on December 22, 2021 for a second term of 5 (Five) consecutive years commencing from December 23, 2021 to December 22, 2026 (both days inclusive). .",
            "news_id": "56ab6749-cbf8-4788-bb9e-c43285392f86",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11679ebe-22cc-44d3-ace3-fa8665132004.pdf",
            "news_date": "2021-08-11 20:02:05",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For Quarter Ended June 30, 2021",
            "news_body": "The Board of Directors of the Company at its Meeting held on August 11, 2021,  inter alia considered and approved the Un-Audited Financial Results for the quarter ended June 30, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> <BR> Enclosed herewith is the copy of the Un-Audited Financial Results for the Quarter ended June 30, 2021 along with Limited Review Report received from the Statutory Auditor of the Company on the Un-Audited Financial Results for the Quarter ended June 30, 2021, Management Report and the Investor Presentation giving highlights of the Company's performance during the said quarter. <BR>",
            "news_id": "f5f3c7d8-e344-4afb-8b04-169fb37dd109",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1bfb38e-e14e-4afb-930e-cae83c401428.pdf",
            "news_date": "2021-08-11 19:57:29",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Company will host an Earnings Call (Virtual) for Investors/Analysts on Thursday, August 12, 2021, at 16:00 hours (IST), during which officials of the Company will discuss the business background/prospects and financial performance of the Company and take questions.",
            "news_id": "bdfe91c0-821c-48fa-97a4-2f6b5749fd9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=679fa9fb-11f5-4f71-8aa7-81dcb502c0c2.pdf",
            "news_date": "2021-08-09 14:50:58",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Reg. 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of disclosure pertaining to Related Party Transactions of the Company for the half year ended March 31, 2021.",
            "news_id": "db678283-3dec-477b-badb-1e6eda002905",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc9257b0-b706-4e18-8dcb-388d88c527de.pdf",
            "news_date": "2021-07-02 15:31:57",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our letter dated June 08, 2021 on Earnings call and  pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the Earnings call held on 8th June, 2021 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/Transcript%20of%20Investor%20Meeting.pdf<BR> <BR> <BR>",
            "news_id": "22502190-4ff0-495d-bc6b-9fb816f21206",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dfcec929-fa7c-4b74-9d6a-65b481d44128.pdf",
            "news_date": "2021-06-14 16:21:47",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Call Conducted On June 08, 2021",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 8th June, 2021 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AudioRecording.mp3<BR> <BR> Written transcript of the same will be submitted in due course.<BR>",
            "news_id": "b4309349-8f2a-4427-81d9-52fbc5133acc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f20336e7-eb44-469d-8bc8-4d007f55f0a4.pdf",
            "news_date": "2021-06-08 23:28:29",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUFICBIO",
            "disp": "Gufic BioSciences",
            "bse_code": 509079,
            "isin": "INE742B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Dated 04.06.2021",
            "news_body": "The Board of Directors of the Company at its Meeting held on June 04, 2021 inter alia considered and approved the following:<BR> 1. Allotment of 1,91,14,506 Equity Shares of the Company of FV of Re. 1/- each to the Shareholders of Gufic Lifesciences Private Limited ('Transferor Company' or 'GLPL')  pursuant to the Scheme of Amalgamation of Gufic Lifesciences Private Limited ('Transferor Company') with the Company ('Transferee Company') and their shareholders and creditors.<BR> 2. The Audited Financial Results for the quarter and financial year ended March 31, 2021. <BR> 3. Recommended Dividend @ 10%  i.e. Re. 0.10 per equity share (Face Value of Re. 1/- each) for the financial year ended March 31, 2021, subject to the approval of the Shareholders at the ensuing Annual General Meeting.<BR> <BR>",
            "news_id": "4ae92b8a-e9c5-44c9-a4a7-d8c3c397da6d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6910725-1f0f-4e8c-b34d-856645f419a0.pdf",
            "news_date": "2021-06-04 20:27:29",
            "seo": "gufic-biosciences-ltd",
            "ltp": 314.5,
            "ch": -2.6000000000000227,
            "pch": -0.8199306212551317,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11606,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}